Reza Fassihi is Director at SCOLR Pharma, Inc. (DDD). They have made 4 open-market trades across 1 company since 2006, most recently 2007-02-02.
CIK 0001270083
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DDD | 50,067 | $139K |
Shares reported on the most recent Form 4, priced at the 2007-02-06 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.